Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
G418 (Geneticin) Single-intraosseous simvastatin injection suppresses cancers via activating C... 2022 Biomed Pharmacother. Yuan W. et al. DOI: 10.1016/j.biopha.2022.113665
pFUSE2-CLIg-hL2 In Silico Maturation of a Nanomolar Antibody against the Human CXCR2. 2022 Biomolecules Buratto D. et al. DOI: 10.3390/biom12091285
pFUSE-CHIg-hG1 In Silico Maturation of a Nanomolar Antibody against the Human CXCR2. 2022 Biomolecules Buratto D. et al. DOI: 10.3390/biom12091285
LTA-SA Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteich... 2022 Respir Res. Pereverzeva L. et al. DOI: 10.1186/s12931-022-02168-6
Blasticidin Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
THP1-Dual™ Cells Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
2'3'-cGAMP Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
Zeocin® Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
THP1-Dual™ KO-STING Cells Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
THP1-Dual™ KO-TREX1 Cells Targeting DNA damage response components induces enhanced STING-dependent typ... 2022 Oncoimmunology Lopez-Pelaez M. et al. DOI: 10.1080/2162402X.2022.2117321
c-di-AMP VacciGrade™ Gut microbiota modulate radiotherapy-associated antitumor immune responses ag... 2022 Gut Microbes Li Z. et al. DOI: 10.1080/19490976.2022.2119055
MDP C/EBPβ Promotes LPS-Induced IL-1β Transcription and Secretion in Alveolar Mac... 2022 J Inflamm Res. Luo Y. et al. DOI: 10.2147/JIR.S377499
Plasmocin® - Mycoplasma Elimination Reagent Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... 2022 Metabolites Maillard M. et al. DOI: 10.3390/metabo12090852
Zymosan Differences in acute phase response to bacterial, fungal and viral antigens i... 2022 Sci Rep. Seltmann A. et al. DOI: 10.1038/s41598-022-18240-6
Poly(I:C) (HMW) VacciGrade™ Differences in acute phase response to bacterial, fungal and viral antigens i... 2022 Sci Rep. Seltmann A. et al. DOI: 10.1038/s41598-022-18240-6
Plasmocin® - Mycoplasma Elimination Reagent Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... 2022 Metabolites Maillard M. et al. DOI: 10.3390/metabo12090852
LL-37 Human Cytomegalovirus Induces Vitamin-D Resistance In Vitro by Dysregulating ... 2022 Viruses Stecher C. et al. DOI: 10.3390/v14092004
Recombinant human IL-1β Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fi... 2022 J Periodontal Res. Abidi A.H. et al. DOI: 10.1111/jre.13050
R848 (Resiquimod) Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is require... 2022 Cell Discov. Yao Y. et al. DOI: 10.1038/s41421-022-00453-8
Zeocin® Targeted immunotherapy against distinct cancer-associated fibroblasts overcom... 2022 Nat Commun. Rivas E.I. et al. DOI: 10.1038/s41467-022-32782-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty